Literature DB >> 30168730

Notch signaling regulates arterial vasoreactivity through opposing functions of Jagged1 and Dll4 in the vessel wall.

Sanchita Basu1, Iulia Barbur1, Alexander Calderon1, Suhanti Banerjee1, Aaron Proweller1.   

Abstract

Functional interactions between endothelial cells (ECs) and smooth muscle cells (SMCs) in the arterial wall are necessary for controlling vasoreactivity that underlies vascular resistance and tone. Key signaling pathways converge on the phosphorylation of myosin light chain (p-MLC), the molecular signature of force production in SMCs, through coordinating the relative activities of myosin light chain kinase (MLCK) and myosin phosphatase (MP). Notch signaling in the vessel wall serves critical roles in arterial formation and maturation and has been implicated in arterial vasoregulation. In this report, we hypothesized that Notch signaling through ligands Jagged1 (in SMCs) and delta-like protein-4 (Dll4; in ECs) regulates vasoreactivity via homotypic (SMC-SMC) and heterotypic (EC-SMC) cell interactions. Using ligand induction assays, we demonstrated that Jagged1 selectively induced smooth muscle MLCK gene expression and p-MLC content while inhibiting MP function (i.e., increased Ca2+ sensitization) in a Rho kinase II-dependent manner. Likewise, selective deficiency of smooth muscle Jagged1 in mice resulted in MLCK and p-MLC loss, reduced Ca2+ sensitization, and impaired arterial force generation measured by myography. In contrast, smooth muscle Notch signaling triggered by Dll4 increased expression of MP-targeting subunit 1 (MYPT1; the MP regulatory subunit), whereas arteries from endothelial Dll4-deficient mice featured reduced MYPT1 levels, enhanced force production, and impaired relaxation independent of endothelium-derived nitric oxide signaling. Taken together, this study identifies novel opposing vasoregulatory functions for ligand-specific Notch signaling in the vessel wall, underscoring instructional signaling between ECs and SMCs and suggesting that Notch signals might behave as a "rheostat" in arterial tone control. NEW & NOTEWORTHY The present study unveils novel roles for ligand-specific Notch signaling in arterial function. Smooth muscle Jagged1 and endothelial cell delta-like protein-4 ligands exhibit selective regulation of myosin light chain kinase and myosin phosphatase-targeting subunit 1/myosin phosphatase, respectively, providing a mechanistic link through which Notch signals modulate contractile activities in vascular smooth muscle. These findings may inform vascular derangements observed in human syndromes of Notch signaling deficiency while offering fundamental molecular insights into arterial physiological function.

Entities:  

Keywords:  Jagged1; Notch signaling; delta-like protein-4; smooth muscle; vasoreactivity

Mesh:

Substances:

Year:  2018        PMID: 30168730      PMCID: PMC6336965          DOI: 10.1152/ajpheart.00293.2018

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  59 in total

1.  Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1.

Authors:  L Li; I D Krantz; Y Deng; A Genin; A B Banta; C C Collins; M Qi; B J Trask; W L Kuo; J Cochran; T Costa; M E Pierpont; E B Rand; D A Piccoli; L Hood; N B Spinner
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

Review 2.  Advances in blood pressure genomics.

Authors:  Patricia B Munroe; Michael R Barnes; Mark J Caulfield
Journal:  Circ Res       Date:  2013-05-10       Impact factor: 17.367

Review 3.  Regulation of Smooth Muscle Myosin Light Chain Phosphatase by Multisite Phosphorylation of the Myosin Targeting Subunit, MYPT1.

Authors:  Justin A MacDonald; Michael P Walsh
Journal:  Cardiovasc Hematol Disord Drug Targets       Date:  2018

4.  Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels.

Authors:  N Villa; L Walker; C E Lindsell; J Gasson; M L Iruela-Arispe; G Weinmaster
Journal:  Mech Dev       Date:  2001-10       Impact factor: 1.882

5.  Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting.

Authors:  I B Lobov; R A Renard; N Papadopoulos; N W Gale; G Thurston; G D Yancopoulos; S J Wiegand
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-12       Impact factor: 11.205

6.  Regulator of G protein signaling 2 deficiency causes endothelial dysfunction and impaired endothelium-derived hyperpolarizing factor-mediated relaxation by dysregulating Gi/o signaling.

Authors:  Patrick Osei-Owusu; Rasna Sabharwal; Kevin M Kaltenbronn; Man-Hee Rhee; Mark W Chapleau; Hans H Dietrich; Kendall J Blumer
Journal:  J Biol Chem       Date:  2012-02-21       Impact factor: 5.157

Review 7.  Myosin phosphatase target subunit: Many roles in cell function.

Authors:  Fumio Matsumura; David J Hartshorne
Journal:  Biochem Biophys Res Commun       Date:  2007-12-26       Impact factor: 3.575

8.  Notch signaling in vascular smooth muscle cells is required to pattern the cerebral vasculature.

Authors:  Aaron Proweller; Alex C Wright; Debra Horng; Lan Cheng; Min Min Lu; John J Lepore; Warren S Pear; Michael S Parmacek
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-01       Impact factor: 11.205

9.  Autoregulatory Control of Smooth Muscle Myosin Light Chain Kinase Promoter by Notch Signaling.

Authors:  Sanchita Basu; Aaron Proweller
Journal:  J Biol Chem       Date:  2015-12-24       Impact factor: 5.157

Review 10.  The myoendothelial junction: breaking through the matrix?

Authors:  Katherine R Heberlein; Adam C Straub; Brant E Isakson
Journal:  Microcirculation       Date:  2009-03-26       Impact factor: 2.628

View more
  2 in total

1.  "Yin and Yang" for Notch signaling in the mature vasculature.

Authors:  Miranda E Good; Brant E Isakson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-09-28       Impact factor: 4.733

2.  Sepsis downregulates aortic Notch signaling to produce vascular hyporeactivity in mice.

Authors:  Vandana Singh; Raut Akash; Gaurav Chaudhary; Rajneesh Singh; Soumen Choudhury; Amit Shukla; Shyama N Prabhu; Neeraj Gangwar; Satish K Garg
Journal:  Sci Rep       Date:  2022-02-21       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.